Results show that genetic variants of TCF7L2 and KCNJ11 genes have potential to emerge as a risk biomarker for T2DM, whereas results of GNB3, GRL and NET genes have been controversial when studied in individuals of different ethnicities. This evidence concerns the gene SLC6A2 and type 2 diabetes mellitus.